Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection

Fig. 4

BCG-Nanocage show great potential in priming and boosting Vγ2Vδ2 T cells in non-human primates. A Schematic diagram of BCG immunization in rhesus macaques. Typical flow images for (B) Vγ2+ T cell, C Vδ2+ T cell and D Vγ2 + Vδ2+ T cell in T cells from PBMC of rhesus macaques before and after BCG immunization. E Schematic diagram of BCG-Nanocage boost immunization in rhesus macaques. Typical flow images for (F) Vγ2+ T cell, G Vδ2+ T cell and H Vγ2 + Vδ2+ T cell in T cells from PBMC of rhesus macaques before and after BCG-Nanocage immunization. I Vγ2+ T cell, J Vδ2+ T cell and K Vγ2 + Vδ2+ T cell in T cells from PBMC of rhesus macaques before and after BCG immunization or BCG-Nanocage immunization

Back to article page